Skip to content

ALPMY Astellas Pharma Inc Unsponsore

Follow

USD (ADR)

6 managers (6 13F filers) reported a position in ALPMY shares at 2026-06-30, 225,486 shares in all. 1 filer opened a position and 1 filer sold out during the quarter.

Managers
6
13F filers
6
New
1
Added
1
Reduced
4
Sold out
1
Shares held by filers
225,486

Shares held by filers adds up every 13F filer's report, so a share reported by a parent and by its subsidiary counts twice (H9). Managers counts each filer group once.

13D and 13G filers

No 13D or 13G on this security in the data. Structured 13D/G data starts 2024-12-18.

Insider trades

No Form 4 transaction on this security in the data.

13F holders, Q2 2026

Filers in the available 13F reports with a share position at 2026-06-30, filer groups collapsed to one row (method), largest first. Options and principal amounts are left out. A group row states no % of portfolio, since each member reports its own portfolio: the members' percents are listed under it. A value about 1,000 times or 1/1,000 of the price other filers imply is shown as filed but neither ranks the row nor enters a sum.

HolderSharesValue% of portfolioChangeSource
HANTZ FINANCIAL SERVICES, INC.189,328$2.53M0.03%-11,37013F-HRTimelineThe filing omitted confidential holdings, a later amendment may add them.
RHUMBLINE ADVISERS21,642$289K<0.01%-16213F-HRTimeline
GAMMA Investing LLC12,434$166K0.01%-33713F-HRTimeline
First Command Advisory Services, Inc.1,278$17.1K<0.01%new13F-HRTimeline
Salomon & Ludwin, LLC734$9.57K<0.01%-1,69813F-HRTimeline
PNC Financial Services Group, Inc.in group PNC Financial Services Group,…70$936<0.01%+1413F-HRTimelineGroup